Chlorpromazine
Chlorpromazine is a first-generation antipsychotic medication belonging to the phenothiazine class, used to treat schizophrenia, other psychotic disorders and manic episodes associated with bipolar disorder. It may also be prescribed for severe nausea and vomiting, persistent hiccups and selected other conditions. Chlorpromazine works primarily by blocking dopamine receptors in the brain, helping reduce psychotic symptoms and regulate certain neurological responses. It is available as oral tablets and, in some settings, injectable formulations. Common side effects include drowsiness, dizziness, dry mouth, constipation and low blood pressure. Important risks include involuntary movements, abnormal heart rhythms, liver problems and neuroleptic malignant syndrome, a rare but serious reaction. Treatment requires medical supervision, and alcohol should be avoided because it can increase sedation.
Chlorpromazine was historically used as a respiratory medicine for the symptomatic management of certain respiratory conditions. Its former uses included:
is okay
The import of medicines into India is regulated by the Central Drugs Standard Control Organisation (CDSCO) under the Drugs and Cosmetics Act, 1940, and the Drugs and Cosmetics Rules, 1945. The regulatory requirements depend on whether the product is an active pharmaceutical ingredient (API), a finished formulation, or an unapproved medicine intended for an individual patient's treatment.
Primeera Healthcare Private Limited can provide import coordination and pharmaceutical documentation assistance for Chlorpromazine, subject to confirmation of its current regulatory status and eligibility for import into India.
The export of Chlorpromazine from India is subject to applicable requirements under the Drugs and Cosmetics Act, 1940, the Drugs and Cosmetics Rules, 1945, and relevant export, customs, and destination-country regulations. Documentation requirements depend on whether the product is an active pharmaceutical ingredient (API), a finished pharmaceutical formulation, or a medicine intended for a specific market. Export eligibility and destination-country requirements must be verified before shipment.
Primeera Healthcare Private Limited can provide pharmaceutical export documentation assistance, regulatory coordination, and shipping support for Chlorpromazine, subject to confirmation of its export eligibility under applicable Indian regulations and the import requirements of the destination country.
If you have any questions or need any help, contact our Support Team. We will get in touch with you within 24 hours from Monday to Friday between 9:00 and 10:00 CET.
All Trademarks and Brands that appear on the website belong to their respective owners. Primeera Healthcare does not lay any claim on them; we only provide information.
